Aclaris Therapeutis (ACRS) PT Raised to $20 at Stifel
Tweet
Share
E-mailGet Alerts ACRS Hot Sheet
Price: $5.92 +2.42%
Rating Summary:
14 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
14 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Stifel analyst Alex Thompson raised the price target on Aclaris Therapeutis (NASDAQ: ACRS) to $20.00 (from $16.00) while maintaining a Buy rating.
You May Also Be Interested In
- Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
- JD Logistics Inc (2618:HK) (JDLGF) PT Raised to HK$18.50 at Macquarie
- Candel Therapeutics Inc. (CADL) PT Raised to $15 at Freedom Broker
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
